Advertisement
Advertisement
AstraZeneca PLC (ZEG.DU)
Dusseldorf - Dusseldorf Delayed Price. Currency in EUR
Follow
At close: 09:01PM CET
Advertisement
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 114.60 |
| Open | 114.55 |
| Bid | 117.25 x 0 |
| Ask | 118.30 x 0 |
| Day's Range | 114.45 - 117.95 |
| 52 Week Range | 97.49 - 136.70 |
| Volume | |
| Avg. Volume | 10 |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Subscribe to Yahoo Finance Plus to view Fair Value for ZEG.DU
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
- Business Wire
TEZSPIRE® approved for self-administration in the US with a new pre-filled pen
WILMINGTON, Del., February 02, 2023--AstraZeneca and Amgen’s TEZSPIRE® (tezepelumab-ekko) has been approved in the US for self-administration in a pre-filled, single-use pen for patients aged 12 years and older with severe asthma. TEZSPIRE is the only biologic approved for severe asthma with no phenotype (e.g. eosinophilic or allergic) or biomarker limitation within its approved label.1
- The Wall Street Journal
U.S. Appeals Court Sides With Drugmakers on Discount Program
The court ruled that drugmakers can limit their shipments of federally discounted drugs to pharmacies, in a blow to hospitals and clinics.
- Yahoo Finance UK
Wall Street flat as earnings roll while FTSE closes in red
UK public borrowing increased by more than expected last month as the government ploughed billions into its subsidies for household bills.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2023 Yahoo. All rights reserved.
